(BBWI) Bath & Body Works - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0708301041

BBWI: Soaps, Candles, Lotions, Fragrances, Sanitizers

Bath & Body Works Inc. (NYSE:BBWI) is a leading specialty retailer primarily focused on home fragrance, body care, and personal hygiene products. The company operates under well-known brands such as Bath & Body Works and White Barn, leveraging a diverse distribution network that includes retail stores across the U.S. and Canada, as well as international partnerships through franchise, license, and wholesale arrangements. This strategic approach allows BBWI to maintain a strong market presence while exploring global growth opportunities.

BBWIs product portfolio encompasses a wide range of items, including candles, soaps, sanitizers, and body care products. The company has successfully expanded its reach through e-commerce, which has been a key driver of recent growth. With a significant number of stores and a robust online platform, BBWI continues to adapt to evolving consumer preferences, ensuring relevance in a competitive retail landscape.

From a financial standpoint, BBWI boasts a market capitalization of approximately $7.68 billion, with a trailing P/E ratio of 8.80 and a forward P/E of 9.58, indicating moderate valuation levels. The price-to-sales ratio of 1.04 reflects a reasonable valuation relative to its revenue. However, the absence of a P/B ratio may signal potential concerns regarding the companys book value, which could be a point of scrutiny for investors.

Investors should consider the risks associated with BBWI, including intense competition in the retail sector, potential disruptions in global supply chains, and the challenges of maintaining growth in a saturated market. Despite these risks, BBWIs strong brand recognition and strategic initiatives position it as a contender in the specialty retail industry, warranting careful consideration for those assessing investment opportunities in this space.

Additional Sources for BBWI Stock

BBWI Stock Overview

Market Cap in USD 7,899m
Sector Consumer Cyclical
Industry Specialty Retail
GiC Sub-Industry Other Specialty Retail
IPO / Inception 1985-07-01

BBWI Stock Ratings

Growth 5y 29.6%
Fundamental 9.92%
Dividend 61.3%
Rel. Strength Industry -33
Analysts 3.85/5
Fair Price Momentum 35.09 USD
Fair Price DCF 30.35 USD

BBWI Dividends

Dividend Yield 12m 2.00%
Yield on Cost 5y 4.41%
Annual Growth 5y 26.91%
Payout Consistency 86.0%

BBWI Growth Ratios

Growth Correlation 3m 22.1%
Growth Correlation 12m -60.8%
Growth Correlation 5y 15.9%
CAGR 5y 17.13%
CAGR/Mean DD 5y 0.50
Sharpe Ratio 12m -0.12
Alpha -31.23
Beta 0.86
Volatility 37.42%
Current Volume 8147.9k
Average Volume 20d 3038.3k
What is the price of BBWI stocks?
As of February 19, 2025, the stock is trading at USD 40.00 with a total of 8,147,896 shares traded.
Over the past week, the price has changed by +12.83%, over one month by +7.27%, over three months by +28.02% and over the past year by -13.74%.
Is Bath & Body Works a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Bath & Body Works is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BBWI as of February 2025 is 35.09. This means that BBWI is currently overvalued and has a potential downside of -12.28%.
Is BBWI a buy, sell or hold?
Bath & Body Works has received a consensus analysts rating of 3.85. Therefor, it is recommend to buy BBWI.
  • Strong Buy: 7
  • Buy: 4
  • Hold: 8
  • Sell: 1
  • Strong Sell: 0
What are the forecast for BBWI stock price target?
According to ValueRays Forecast Model, BBWI Bath & Body Works will be worth about 41 in February 2026. The stock is currently trading at 40.00. This means that the stock has a potential upside of +2.5%.
Issuer Forecast Upside
Wallstreet Target Price 45.9 14.7%
Analysts Target Price 45.3 13.4%
ValueRay Target Price 41 2.5%